Deep Generative AI Models Analyzing Circulating Orphan Non-coding RNAs Enable Detection of Early-stage Lung Cancer
Overview
Authors
Affiliations
Liquid biopsies have the potential to revolutionize cancer care through non-invasive early detection of tumors. Developing a robust liquid biopsy test requires collecting high-dimensional data from a large number of blood samples across heterogeneous groups of patients. We propose that the generative capability of variational auto-encoders enables learning a robust and generalizable signature of blood-based biomarkers. In this study, we analyze orphan non-coding RNAs (oncRNAs) from serum samples of 1050 individuals diagnosed with non-small cell lung cancer (NSCLC) at various stages, as well as sex-, age-, and BMI-matched controls. We demonstrate that our multi-task generative AI model, Orion, surpasses commonly used methods in both overall performance and generalizability to held-out datasets. Orion achieves an overall sensitivity of 94% (95% CI: 87%-98%) at 87% (95% CI: 81%-93%) specificity for cancer detection across all stages, outperforming the sensitivity of other methods on held-out validation datasets by more than ~ 30%.
Zhong Y, He J, Huang C, Lai H, Li X, Zheng C J Transl Med. 2025; 23(1):326.
PMID: 40087753 DOI: 10.1186/s12967-025-06326-4.
Karimzadeh M, Momen-Roknabadi A, Cavazos T, Fang Y, Chen N, Multhaup M Nat Commun. 2024; 15(1):10090.
PMID: 39572521 PMC: 11582319. DOI: 10.1038/s41467-024-53851-9.